Michel Detheux, Chief Executive Officer at iTeos Therapeutics, Inc. (ITOS), sold 88,851 shares at $44.31 ($4.0M) on 2021-12-22, disclosed to the SEC on 2021-12-22.
Open-market sale of $4.0M ITOS by Chief Executive Officer. Not flagged as scheduled, tax-driven, or recurring — but no specific bearish signal from our filters. Reasons for insider sales vary widely.
Something here stands out, but not much.
| # | Price | Shares | Value | % of Total |
|---|---|---|---|---|
| 1 | $43.94 | 9,111 | $400K | 10.1% |
| 2 | $43.94 | 9,111 | $400K | 10.1% |
| 3 | $44.15 | 13,646 | $602K | 15.2% |
| 4 | $44.15 | 13,646 | $602K | 15.2% |
| 5 | $45.06 | 5,580 | $251K | 6.4% |
| 6 | $45.06 | 5,580 |
| $251K |
| 6.4% |
| 7 | $44.31 | 1,514 | $67K | 1.7% |
| 8 | $44.31 | 1,514 | $67K | 1.7% |
| 9 | $44.62 | 5,007 | $223K | 5.6% |
| 10 | $44.62 | 5,007 | $223K | 5.6% |
| 11 | $44.92 | 149 | $7K | 0.2% |
| 12 | $45.37 | 9,493 | $431K | 10.9% |
| 13 | $45.37 | 9,493 | $431K | 10.9% |
| Total | $44.54 avg | 88,851 | $4.0M | 100% |
| Filing → |
| ITOS | SELL | 2022-04-19 | $732K | — | Filing → |
| ITOS | SELL | 2022-03-22 | $1.2M | — | Filing → |
| ITOS | SELL | 2022-02-24 | $977K | — | Filing → |